Clinical Trials Browser

Interventional × Disease × Doxorubicin × Clear all

NCT00128856 2023-03-06

Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients

Phase 2 Completed

Breast Neoplasms, Disease

NCT01659099 2018-03-07

GAINED

Phase 3 Terminated

Disease, Lymphoma